Screener
AbCellera Biologics Inc. ABCL Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s net income?
- AbCellera Biologics Inc. (ABCL) reported net income of -$55.43M in Q2 2026.
- How has AbCellera Biologics Inc.'s net income changed year-over-year?
- AbCellera Biologics Inc.'s net income decreased by 59.6% year-over-year, from -$34.73M to -$55.43M.
- What is the long-term trend for AbCellera Biologics Inc.'s net income?
- Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s net income has grown at a -1.6% compound annual growth rate (CAGR), from $153.47M to -$146.41M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about AbCellera Biologics Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude